Send this article to a friend Print the page 

logo Mitologics
Let the Mitochondria answer
image plaque

November 2017

Bio-Europe 2017. November 6-7, 2017, Berlin (Germany)

October 2017

Cosmetic 360. October 18-19, 2017, Paris (France)

July 2017

AFSSI UE 2017. July 11-13, 2017, Marseille (France)

Rseau MeetOchondries May 14 - 17, 2017

Mitologics CEO, Dr Annie Borgne-Sanchez is invited speaker at the next meeting of the Réseau MeetOchondries, taking place May 14-17, 2017 in Hossegor (France). Title: Impact des médicaments contaminants environnementaux sur les fonctions mitochondriales et le métabolisme

 

 

BIO EUROPE Nov 7 - 9, 2016

Mitologics will attend BIO EUROPE in Köln November 7 to 9th, 2016

7th World Congress on Mitochondrial Targeting, 24-26 October 2016 Berlin, Germany

Mitologics will attend the 7th World Congress on Mitochondrial Targeting, 24-26 October 2016 Berlin, Germany

Innovation Days October 3-4, 2016

Mitologics will be present at Innovation Days in Paris (France) in October 3-4, 2016

Strategic partnership with Toxys - March 2016

Toxys and Mitologics announce a strategic partnership to jointly offer their unique in vitro toxicity assays. The unique combination of the ToxTracker® assay and the MiToxView® platform provides a valuable approach for reliable identification of the hazardous properties of new compounds and nanomaterials and gain insight into their mechanisms of action.

March 2016

Society of Toxicology 55th Annual Meeting and ToxExpo March 13–17, 2016

Society of Toxicology 55th Annual Meeting and ToxExpo March March 13–17, 2016

The attendees of the next Society of Toxicology 55th Annual Meeting and ToxExpo, March 13–17, 2016, in New Orleans, Louisiana, are invited to meet Mitologics' team at booth 327. Mitologics will present the last developments of its screening toxicity platform MiToxView during 2 poster sessions: 1-In vitro prediction of antiretroviral drug-induced hepatotoxicity by using mitochondrial MiToxView® screening platform. 2-Exploration of drug-induced mitochondrial toxicity mechanisms on hepatic mitochondria and cultured cells (presented by L'Oréal).

October 2015

Mitologics is sponsor of the 6th World Congress on Targeting Mitochondria, taking place October 28-30, 2015 in Berlin, Germany. The company will present its new R&D datas on MiToxView predictive toxicology platform.

May 2015

Mitologics CEO, Dr Annie Borgne-Sanchez is invited speaker at the next meeting of the Réseau MeetOchondries, taking place May 10-13, 2015 in Guidel, (France). Title: Combinaison de tests sur mitochondries isolées et cellules HepaRG pour la prédiction des risques d’hépatotoxicité chez l’homme.

January 2015

Mitologics CEO, Dr Annie Borgne-Sanchez is invited speaker at the next Targeting Mitochondrial Dysfunction and Toxicity Conference (CHI), taking place March 19-20, 2015 in Cambridge, MA (USA). Title: Use of Multiparametric Assays on Isolated Liver Mitochondria and HepaRG Cells to predict DILI.

August 2014

Mitologics will present its new R&D datas on predictive toxicology at the EUROTOX 2013 Congress, September 1-4, 2013 in Interlaken (CH): "Prediction of Drug-Induced Liver Injury in Human with a Multiparametric Assay on the HepaRG® Cell Line" P12-64.

September 2014

Annie Borgne-Sanchez will present Mitologics' latest results on HepaRG model:
"Identification of drug-induced mitochondrial alterations using the HepaRG cell line"
At the 19th North America ISSX meeting - October 19-23, 2014 - San Francisco, CA, USA.

October 2013

BAYER Oncology department published new datas generated on Mitologics screening platform : BAY 87-2243, a highly potent and selective inhibitor of hypoxia-induced gene activation has antitumor activities by inhibition of mitochondrial complex I. Ellinghaus P et al., 2013 in Cancer Med 2(5):611-24.